The number of cases of Candida auris (C. auris), a dangerous multidrug-resistant fungus, in the U.S. has grown from 7 to 122 over the past 9 months, the CDC says in its Morbidity and Mortality Weekly Report. [1]
For many years, the only known link between Candida spp. infections, and cancer was that it is an opportunistic pathogen taking advantage of the immune system damage caused by chemo. Recently, new research has found that Candida albicans can actually also promote cancer by producing carcinogens, causing inflammation, increasing the response of Th17 cells, and molecular mimicry of our own immune cells.
